People who should take aspirin daily

Amman Today

publish date 2021-11-20 16:31:43

Jordan News

If you take a daily aspirin to reduce your chances of having a heart attack or stroke, see your doctor, as a new report suggests that over-the-counter medications may do more harm than good for some patients.

Aspirin, a pain reliever and blood thinner, is often used to reduce the possibility of blood clots. This is always useful for those who have a history of heart disease or who have had a heart attack, stroke, or other blockage in a blood vessel.

However, blood thinners can also increase the risk of bleeding and may not be beneficial for people who do not have heart disease or for those who are not fully aware of their family history and individual risk factors.

According to the US Preventive Services Team, adults age 60 and older who take a daily aspirin have an increased risk of bleeding, and those without a history of heart attack, stroke, or other obstruction may outweigh the benefits of taking a daily aspirin.

There may be little benefit for younger patients (ages 40 to 50) with aspirin, especially if they have a low risk of bleeding, but the supporting evidence becomes less clear with age.

It is very important to talk to your doctor about taking or stopping daily aspirin. It’s important to know your family history and other medical conditions so that your health care provider can make correct, informed recommendations for you.

The change in guidelines does not apply to patients who are taking (or have been advised to take) a daily low-dose aspirin after a heart attack or stroke.

Other people who may be advised to take a daily aspirin include: Those who have high blood pressure, high cholesterol, or people with diabetes.

There are other medical conditions that can increase the chance of a heart attack or stroke, so consult your doctor before using any medications or supplements.

#People #aspirin #daily

Jordan Miscellaneous news

Source : اخبار الاردن

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button